Vaxcyte (PCVX) Other Non Operating Income (2019 - 2026)

Vaxcyte (PCVX) has 8 years of Other Non Operating Income data on file, last reported at -$1.4 million in Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 119.36% year-over-year to -$1.4 million in Q1 2026; TTM through Mar 2026 was $28.8 million, a 478.57% increase from a year earlier, with the FY2025 full-year figure at $37.3 million, up 953.23% from the prior year.
• Other Non Operating Income for Q1 2026 stood at -$1.4 million, down from $1.3 million in the prior quarter.
• Over the last five years, Other Non Operating Income for PCVX reached as high as $28.6 million in Q2 2025 and fell as low as -$47.0 million in Q4 2023.
• Historically, Other Non Operating Income has averaged $2.4 million across 5 years, with a median of $465000.0 in 2024.
• Across the five-year window, Other Non Operating Income sank 3498.04% in 2022 and surged 6044.73% in 2025, its largest moves.
• Year by year, Other Non Operating Income stood at $8.5 million in 2022, then tumbled by 651.82% to -$47.0 million in 2023, then soared by 75.83% to -$11.4 million in 2024, then surged by 111.65% to $1.3 million in 2025, then tumbled by 204.3% to -$1.4 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were -$1.4 million in Q1 2026, $1.3 million in Q4 2025, and $291000.0 in Q3 2025.